EarningsQ4 2024 Earnings Report

ANI Pharmaceuticals (BSFA) Q4 2024 Earnings Report

0 Followers

CH:BSFA Q4 2024 EPS Results

Actual EPSCHF1.36

Consensus EPSCHF1.19

Beat/MissBeat by +CHF0.16

One Year Ago EPSCHF0.83

Actual RevenueCHF158.59M

Expected RevenueCHF145.93M

Beat/MissBeat by +CHF12.66M

YoY Revenue Growth+44.75%

QuarterQ4 2024

Date02/28/2025

TimeBefore Open

Conference CallFriday, February 28, 2025

CH:BSFA Upcoming Earnings

ANI Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

CH:BSFA Q4 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	1.81 / -	1.698	―
Aug 07, 2026	2026 (Q2)	1.70 / 1.84	1.498	22.78% (+0.34)
May 08, 2026	2026 (Q1)	1.08 / 1.71	1.415	20.59% (+0.29)
Mar 03, 2026	2025 (Q4)	1.66 / 1.94	1.356	42.94% (+0.58)
Nov 10, 2025	2025 (Q3)	1.47 / 1.70	1.115	52.24% (+0.58)
Aug 08, 2025	2025 (Q2)	1.17 / 1.50	0.849	76.47% (+0.65)
May 09, 2025	2025 (Q1)	1.15 / 1.41	1.007	40.50% (+0.41)
Feb 28, 2025	2024 (Q4)	1.19 / 1.36	0.832	63.00% (+0.52)
Nov 08, 2024	2024 (Q3)	0.90 / 1.12	1.057	5.51% (+0.06)
Aug 06, 2024	2024 (Q2)	0.79 / 0.85	1.065	-20.31% (-0.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed